22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here


Latest Presentations

22nd Century Overview
View Presentation

22nd Century Overview of GVB Biopharma Acquisition
View Presentation

Our Hops Franchise and Market Overview
View Presentation

Investor Contact Information


22nd Century Group, Inc.
500 Seneca Street, Suite 507
Buffalo, NY 14204
T: 716-270-1523
Contact Us

Investor Relations

Mei Kuo
22nd Century Group, Inc.
Director, Communications & Investor Relations
T: 716-300-1221

Darrow Associates Investor Relations
Matt Kreps
T: 214-597-8200

Transfer Agent

Continental Stock and Transfer Company
1 State Street, 30th Floor
New York, NY 10004
T: 212-509-4000